Search
Close this search box.

Multiple sclerosis registries in Europe - Updated overview

In 2018, an updated mapping of multiple sclerosis (MS) registries in Europe was conducted, building on a previous survey from 2014. This survey includes 19 registries, mostly from Europe, and provides detailed information on the organization, data collection methods, quality control mechanisms, and funding of these registries. The study highlights the importance of MS registries for clinical practice, research, and regulatory purposes, identifying areas that could contribute to improving data collection and utilization in international collaborations.

Glaser, A., Stahmann, A., Meissner, T., Flachenecker, P., Horáková, D., Zaratin, P., Brichetto, G., Pugliatti, M., Rienhoff, O., Vukusic, S., de Giacomoni, A. C., Battaglia, M. A., Brola, W., Butzkueven, H., Casey, R., Drulovic, J., Eichstädt, K., Hellwig, K., Iaffaldano, P., Ioannidon, E., Kuhle, E., Lycke, K., Magyari, M., Malbasa, T., Middelton, R., Myhr, K. M., Notas, K., Orologas, A., Otero-Romero, S., Pekmezovic, T., Sastre-Garriga, J., Seeldrayers, P., Soilu-Hännien, M., Stawiarz, L., Trojano, M., Zeimssen, T., Hilletr, J., Thalheim, C. (2019). Multiple sclerosis registries in Europe - An updated mapping survey. In Multiple Sclerosis and Related Disorders (Vol. 27, pp. 171-178). Elsevier BV. https://doi.org/10.1016/j.msard.2018.09.032 PMID: 30384204

Entire paper is available after login to the website of the Multiple Sclerosis and Related Disorders.

Archive

Page intended exclusively for healthcare professionals

Dear Visitors,

Please be informed that the following webpage is intended exclusively for healthcare professionals as defined by the advertising regulation law, specifically for individuals authorized to prescribe or dispense medicinal products.

The content of this page is therefore not intended for the general public, particularly not for everyday consumers. There is a risk that the information could be misunderstood or misinterpreted by those without the appropriate expertise, potentially leading to incorrect diagnoses or treatment decisions, and thus posing a health risk.

I declare that I am a healthcare professional and acknowledge that the information displayed here is not intended for the general public.

Newsletter of the ReMuS registry

Occasionally, we will send you news from the field of multiple sclerosis research and the ReMuS registry in the form of a digital newsletter.